Overview

Concurrent Chemoradiotherapy Containing Paclitaxel&Cisplatin With/Without Tarceva in Locally Advanced Esophageal Cancer

Status:
Unknown status

Trial end date:
2014-12-01

Target enrollment:

Participant gender:

Summary

This study is multi-center randomized phase III one to evaluate the difference in local-control and survival rate between patients receiving concurrent chemoradiotherapy combined Tarceva or not.

Phase:

Phase 3

Details

Lead Sponsor:

Wenzhou Medical University

Treatments:

Albumin-Bound Paclitaxel
Cisplatin
Erlotinib Hydrochloride
Paclitaxel